Updated Feb. 26, 2026, 9:20 a.m.
Mississippi’s “Right to Try Medical Cannabis Act” has successfully passed a Senate committee, offering expanded access to medical cannabis for patients who do not meet existing qualification criteria. This development allows physicians to petition for a patient’s inclusion in medical cannabis programs, even if they lack a qualifying condition.
The Senate public health committee, predominantly Republican with 19 members, convened on February 24 to discuss this initiative led by Rep. Lee Yancey, R-Brandon. Under current Mississippi law, approximately 20 medical conditions qualify individuals for medical marijuana, including cancer and post-traumatic stress disorder. Proponents argue the proposed legislation recognizes the needs of patients who could benefit from cannabis but currently do not qualify.
If enacted, the bill would permit primary care providers to request approval from State Health Officer Dr. Daniel Edney for patients seeking medical cannabis treatment. The petition process requires a comprehensive medical history, justification for how cannabis could be beneficial, and a detailed treatment plan. Edney would evaluate submissions and retain the authority to approve or deny each request within 45 days.
At the committee hearing, Edney highlighted challenges faced by hospice programs, which have been hesitant to participate in the medical cannabis framework despite recognizing patient needs. He noted that this legislation would streamline the process, allowing smaller practices to submit targeted petitions instead of engaging in extensive licensing requirements.
Another significant aspect of the bill, as indicated by Sen. Kevin Blackwell, R-Southaven, is the provision to extend medical cannabis access to out-of-state residents seeking treatment in Mississippi. This adjustment reflects the growing demand for such services and positions Mississippi as a more hospitable environment for medical cannabis compared to neighboring states like Tennessee and Alabama.
The measure received unanimous support in the Senate committee and will soon be presented to the full chamber for a vote, with advocates optimistic about its potential impact on patient care, particularly in end-of-life situations.
In addition to the “Right to Try” legislation, the committee addressed another proposed bill that would grant terminally ill patients access to medical marijuana while hospitalized. However, this bill faced significant scrutiny over potential liability issues for healthcare providers and concerns about drug interactions with existing treatments. Critics, including Sen. Angela Burks Hill, R-Picayune, expressed reservations about the complications that could arise from allowing medical marijuana usage in hospitals.
Despite these concerns, supporters emphasized the importance of providing terminally ill patients with access to relief during their final months. The committee ultimately voted on the hospital access bill, which narrowly failed, allowing for possible reconsideration in the upcoming meeting on March 3.
The developments indicate a dynamic landscape for medical cannabis in Mississippi, influencing both patient care and legislative approaches within the state. This evolving framework highlights Mississippi’s distinctive position in the broader cannabis market, paving the way for more inclusive policies that may shape future industry growth.
